Commission Implementing Regulation (EU) 2016/1068

of 1 July 2016

approving N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine) as an existing active substance for use in biocidal products of product-type 18

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products1, and in particular the third subparagraph of Article 89(1) thereof,

Whereas:

(1)
Commission Delegated Regulation (EU) No 1062/20142 establishes a list of existing active substances to be evaluated for their possible approval for use in biocidal products. That list includes N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine).
(2)

Cyromazine has been evaluated for use in products of product-type 18, Insecticides, acaricides and products to control other arthropods, as described in Annex V to Regulation (EU) No 528/2012.

(3)

Greece was designated as evaluating competent authority and submitted the assessment reports together with its recommendations on 28 August 2014.

(4)

In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 10 December 2015 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.

(5)

According to that opinion, biocidal products of product-type 18 and containing cyromazine may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.

(6)

It is therefore appropriate to approve cyromazine for use in biocidal products of product-type 18, subject to compliance with certain specifications and conditions.

(7)
Since cyromazine meets the criteria for being very persistent (vP) according to Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council3, treated articles treated with or incorporating cyromazine should be labelled appropriately when placed on the market.
(8)

A reasonable period should be allowed to elapse before an active substance is approved in order to permit interested parties to take the preparatory measures necessary to meet the new requirements.

(9)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

Article 1

N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine) is approved as an active substance for use in biocidal products of product-type 18, subject to the specifications and conditions set out in the Annex.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 1 July 2016.

For the Commission

The President

Jean-Claude Juncker

ANNEX

Common Name

IUPAC NameIdentification Numbers

Minimum degree of purity of the active substance4

Date of approval

Expiry date of approval

Product type

Specific conditions

Cyromazine

IUPAC Name:

N-cyclopropyl-1,3,5-triazine-2,4,6-triamine

EC No: 266-257-8

CAS No: 66215-27-8

950 g/kg

1 January 2018

31 December 2027

18

The authorisations of biocidal products are subject to the following conditions.

  1. (1)

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.

  2. (2)

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:

    1. (a)

      professional users;

    2. (b)

      the surface water, sediment and soil compartment for products used in animal housing.

  3. (3)
    For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council5 or Regulation (EC) No 396/2005 of the European Parliament and of the Council6 shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.

The placing on the market of treated articles is subject to the following condition:

The person responsible for the placing on the market of a treated article treated with or incorporating cyromazine shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.

4

The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.

5

Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).

6

Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC (OJ L 70, 16.3.2005, p. 1).